Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
P SorokinM NovozhilovD UtkinZ AbduragimovaI DudinaA NikiforchinS KulikovaPublished in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti (2024)
Sentinel lymph node biopsy using indocyanine green is a safe procedure and allows tailoring adjuvant therapy in presumed low- and intermediate-risk endometrial cancer. It assists in avoiding external beam radiotherapy overtreatment and introducing additional modalities when necessary.